Aeromonas infection is a bacterial disease caused by gram-negative bacteria of the genus Aeromonas, most commonly Aeromonas hydrophila. These opportunistic pathogens are ubiquitous in aquatic environments and moist soil, making them a significant concern for snake keepers, particularly those maintaining species with access to water features or living in humid enclosures. Aeromonas bacteria are considered opportunistic because they typically require some predisposing factor such as stress, immunosuppression, or tissue damage to establish infection in otherwise healthy snakes.
Aeromonas infections can affect virtually any snake species, though they are most frequently encountered in aquatic and semi-aquatic species such as garter snakes and water snakes that have regular contact with standing water. The bacteria can also affect terrestrial species when husbandry conditions promote bacterial proliferation, particularly when enclosure hygiene is poor or humidity levels are excessively high. Wild-caught snakes and those kept in suboptimal conditions face the highest risk of developing clinical disease from Aeromonas exposure.
The impact of Aeromonas infection on snake health ranges from localized skin lesions to life-threatening systemic septicemia. Because snakes are ectothermic, their immune response is heavily dependent on environmental temperature, and snakes kept at suboptimal temperatures are significantly more susceptible to bacterial infections including Aeromonas. The bacteria can establish infection through breaks in the skin, the respiratory tract, or the gastrointestinal system, potentially spreading throughout the body if left untreated.
Aeromonas infections are treatable when caught early and addressed with appropriate antibiotic therapy guided by culture and sensitivity testing. However, the key to successful treatment lies in early detection and concurrent correction of any underlying husbandry deficiencies that predisposed the snake to infection. Finding a veterinarian experienced in reptile medicine is essential, as treatment protocols differ significantly from those used in mammals, and antibiotic selection must account for the gram-negative nature of these bacteria.
